selegiline has been researched along with Hypoglycemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bransome, ED; Hendry, LB; Rowland, MJ | 1 |
| Ekblom, J; Oreland, L; Tottmar, O | 1 |
2 other study(ies) available for selegiline and Hypoglycemia
| Article | Year |
|---|---|
Hypoglycemia caused by selegiline, an antiparkinsonian drug: can such side effects be predicted?
Topics: Aged; Computer Simulation; DNA; Glucose; Humans; Hypoglycemia; Insulin; Male; Monoamine Oxidase Inhibitors; Nucleic Acid Conformation; Parkinson Disease; Selegiline | 1994 |
Cytoprotection by deprenyl and tolcapone in a cell culture model of cerebral ischaemia.
Topics: Animals; Benzophenones; Brain Ischemia; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cell Hypoxia; Cells, Cultured; Cytoprotection; Drug Combinations; Female; Hypoglycemia; In Situ Nick-End Labeling; L-Lactate Dehydrogenase; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Nitrophenols; Pregnancy; Prosencephalon; Rats; Rats, Sprague-Dawley; Selegiline; Tolcapone | 1998 |